Global Ligation Devices Market Size study & Forecast, by Product (Hand-held Instruments, Accessories), by Procedure (Minimally Invasive, Open Surgery), by Application (Gynaecology, Cardiovascular Applications, Gastrointestinal and Abdominal Applications,

Global Ligation Devices Market Size study & Forecast, by Product (Hand-held Instruments, Accessories), by Procedure (Minimally Invasive, Open Surgery), by Application (Gynaecology, Cardiovascular Applications, Gastrointestinal and Abdominal Applications, Others) and Regional Analysis, 2023-2030

Global Ligation Devices Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Ligation devices, also known as legators, are medical instruments used in surgical procedures to ligate (tie off) blood vessels or other structures. The purpose of ligation is to occlude or close off the vessel or structure, preventing bleeding or controlling the flow of fluids. Ligation devices are commonly used in various surgical specialities, including general surgery, cardiovascular surgery, gynecology, and orthopedic surgery. The Ligation Devices market is expanding because of factors such as the rise in the prevalence of cardiovascular & urological diseases, the increasing number of minimally invasive procedures.

Ligation devices play a crucial role in the management and treatment of certain cardiovascular and urological conditions. For example, in cardiovascular medicine, ligation devices are used in procedures such as ligating blood vessels or ducts to prevent bleeding or to close off abnormal vessels. In urology, ligation devices can be used in surgeries such as vasectomy or for controlling bleeding during kidney surgeries. The increasing prevalence of these diseases has likely led to a higher demand for medical devices such as ligation devices The American College of Cardiology reports that by 2030, there would be around 29 million Americans with a diagnosis of cardiovascular disease, up from 6.95 million in the year 2021. In 2020, 244.1 million people worldwide were living with ischemic heart disease. Moreover, According to the Global Forum on Incontinence, 2020, approximately 400 million people globally experience urine incontinence or 4-8% of the population. In addition, according to the Journal of Urology 2018, 12% of the world's population is predicted to have urolithiasis by 2025. Thus, the rising prevalence of cardiovascular and urological diseases across the globe is driving market growth. In addition, the increasing number of bariatric surgeries and aesthetic surgeries and the surge in healthcare spending for the treatment of diseases are some factors creating new opportunities for market growth. However, the high cost of ligation devices and non-invasive alternatives stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Ligation Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing disease prevalence, the presence of key market players, and rising healthcare expenditure for research and development activities. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising demand for non-invasive surgeries, rising prevalence of diseases, an increase in the number of collaborations for laser technology development, and geographic expansion of key players in the region.

Major market player included in this report are:
Johnson & Johnson
Medtronic plc
Teleflex Incorporated
Olympus Corporation
Applied Medical Distribution Corporation
CONMED Corporation
CooperSurgical Inc.
Progressive Medical, Inc.
Grena Ltd
B. Braun Group

Recent Developments in the Market:
In December 2020, ConMed Corporation and PhyzioTech, Inc. established a partnership to create and market a line of minimally invasive surgical instruments, including ligation devices, for the treatment of pelvic floor problems. The company's product range was strengthened across the market thanks to this new launch.

Global Ligation Devices Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Product, Procedure, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Hand-held Instruments
Accessories

By Procedure:
Minimally Invasive
Open Surgery

By Application:
Gynaecology
Cardiovascular Applications
Gastrointestinal and Abdominal Applications
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Johnson & Johnson
Medtronic plc
Teleflex Incorporated
Olympus Corporation
Applied Medical Distribution Corporation
CONMED Corporation
CooperSurgical Inc.
Progressive Medical, Inc.
Grena Ltd
B. Braun Group

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.